Nicholas Haft, Director at Finch Therapeutics Group, Inc. (FNCH), bought 1,248,444 shares at $17.00 ($15.0M) on 2021-03-23, disclosed to the SEC on 2021-03-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 366,093 | $0 | 0.0% |
| 2 | $17.00 | 882,351 | $15.0M | 100.0% |
| Total | $12.01 avg | 1,248,444 | $15.0M | 100% |